|
|
Your search for: 'Effects* AND Engl*' |
Documents 1 - 3 of 3 matches |
|
1. (Journal Article): Reversal of lesions of diabetic nephropathy after pancreas transplantation.
Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M ABSTRACT:
BACKGROUND: In patients with type I diabetes mellitus who do not have uremia and have not received a kidney transplant, pancreas transplantation does not ameliorate established les...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T1DM
»
Pancreas Transplanta...
»
Diabetic Nephropathy
»
Journal Article
submitted: Apr 05, 2006 |
|
2. (Journal Article): Anti-diabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S ABSTRACT:
BACKGROUND. Glucagon-like peptide-1 (7-36) amide (glucagon-like insulinotropic peptide, or GLIP) is a gastrointestinal peptide that potentiates the release of insulin in physiologi...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T2DM
»
Insulinotropic Subst...
»
Incretins
»
GLP-1
»
Journal Article
submitted: Nov 16, 2005 |
|
3. (Journal Article): Incretin mimetics as emerging treatments for type 2 diabetes.
Joy SV, Rodgers PT, Scates AC ABSTRACT:
OBJECTIVE: To review the physiology, pharmacology, and clinical efficacy of glucagon-like peptide (GLP-1) and the incretin mimetics exenatide and liraglutide in clinical studies. D...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Anti-Hyperglycemic a...
»
Incretin Hormones
»
GLP-1
»
Effectivity of GLP-1...
»
Journal Article
submitted: Nov 29, 2005 |
|
|
|
|